Li P, Li Z, Staton E, Umpierrez GE, Davis G, Shao H, Pasquel FJ. GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes. JAMA. 2024 Oct 23. doi: 10.1001/jama.2024.18581.
Li P, Ali MK, Narayan KMV, Umpierrez GE, Fonseca VA, Shi L, Shao H. Value-Based Pricing and Its Implications for the Newly Announced Medicare Negotiated Price Under the Inflation Reduction Act. Diabetes Care. 2025 Jan 22:dc242403. doi: 10.2337/dc24-2403.
Li P, Spector E, Alkhuzam K, Patel R, Donahoo WT, Bost S, Lyu T, Wu Y, Hogan W, Prosperi M, Dixon BE, Dabelea D, Utidjian LH, Crume TL, Thorpe L, Liese AD, Schatz DA, Atkinson MA, Haller MJ, Shenkman EA, Guo Y, Bian J, Shao H. Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida+ clinical research network. Diabetes Obes Metab.2024 Sep. doi: 10.1111/dom.15987.
Li P, Kianmehr H, Guan D, Kulshreshtha A, Narayan KMV, Ali MK, Umpierrez GE, Hu X, Fonseca VA, Shi L, Shao H. Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial. Diabetes Obes Metab. 2024 Sep;26(9):3958-3968. doi: 10.1111/dom.15744.
Li P, Alkhuzam K, Brown J, Zhang Y, Jiao T, Guo J, Umpierrez GE, Narayan KMV, Kulshreshtha A, Pasquel FJ, Ali MK, Shao H. Association between low cognitive performance and diabetes-related health indicators across racial and ethnic groups in adults with diabetes. Diabetes Obes Metab. 2024 Sep;26(9):3723-3731. doi: 10.1111/dom.15715.
Li P, Lyu T, Alkhuzam K, Spector E, Donahoo WT, Bost S, Wu Y, Hogan WR, Prosperi M, Schatz DA, Atkinson MA, Haller MJ, Shenkman EA, Guo Y, Bian J, Shao H. The role of health system penetration rate in estimating the prevalence of type 1 diabetes in children and adolescents using electronic health records. J Am Med Inform Assoc. 2023 Dec 22;31(1):165-173. doi: 10.1093/jamia/ocad194.
Li P, Zhang P, Guan D, Guo J, Zhang Y, Pavkov ME, Bullard KM, Shao H. Changes in racial and ethnic disparities in glucose-lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005-2018. Diabetes Obes Metab. 2023 Feb;25(2):516-525. doi: 10.1111/dom.14894.
Li P, Patel R, Guo J, Vouri SM, Shi L, Fonseca V, Shao H. The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010-2018. Curr Med Res Opin. 2021 Nov;37(11):1875-1880. doi: 10.1080/03007995.2021.1971181.
Li P, Abuloha S, Alshehri A, et al. Glycemic control, medications, and onset of Alzheimer’s disease and related dementias: A scoping review on diabetes management in people with mild cognitive impairment. Healthcare and Rehabilitation. 2025;1(1):100008. doi:10.1016/j.hcr.2024.100008
Shao H, Thorpe LE, Islam S, Bian J, Guo Y, Li P, Bost S, Dabelea D, Conway R, Crume T, Schwartz BS, Hirsch AG, Allen KS, Dixon BE, Grannis SJ, Lustigova E, Reynolds K, Rosenman M, Zhong VW, Wong A, Rivera P, Le T, Akerman M, Conderino S, Rajan A, Liese AD, Rudisill C, Obeid JS, Ewing JA, Bailey C, Mendonca EA, Zaganjor I, Rolka D, Imperatore G, Pavkov ME, Divers J; DiCAYA Writing Group. Developing a Computable Phenotype for Identifying Children, Adolescents, and Young Adults With Diabetes Using Electronic Health Records in the DiCAYA Network. Diabetes Care. doi: 10.2337/dc24-1972.
Alkhuzam K, Li P, Abuloha S, Xue Q, Shi L, Fonseca V, Zhang Y, Shao H. Long-term Health Benefit and Economic Return of Time in Range (TIR) Improvement in Individuals with Type 2 Diabetes. Diabetes Obes Metab. doi: 10.1111/dom.16168.
Jiao T, Kianmehr H, Lin Y, Li P, Singh Ospina N, Ghayee HK, Ruzieh M, Fonseca V, Shi L, Zhang P, Shao H. Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data. Diabetes Obes Metab. 2024 Apr;26(4):1502-1509. doi: 10.1111/dom.15453.
Alshehri A, Guan D, Li P, Zhang Y, Ghayee HK, Jiao T, Shao H. Trends in utilization patterns of newer glucose-lowering drugs in US adults with type 2 diabetes and a history of coronary heart disease or heart failure: 2005-2019. Prim Care Diabetes. 2024 Oct;18(5):561-563. doi: 10.1016/j.pcd.2024.07.003.
Guan D, Lewis MO, Li P, Zhang Y, Zhang P, Tang S, Brown J, Guo J, Zhang Y, Shao H. Incremental burden on health-related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non-institutionalized people with diabetes aged 65 years and older. Diabetes Obes Metab. 2024 Jan;26(1):275-282. doi: 10.1111/dom.
Wang GH, Li P, Wang Y, Guo J, Wilson DL, Lo-Ciganic WH. Association between Antidepressants and Dementia Risk in Older Adults with Depression: A Systematic Review and Meta-Analysis. J Clin Med. 2023 Oct 3;12(19):6342. doi: 10.3390/jcm12196342.
Shao H, Li P, Guo J, Fonseca V, Shi L, Zhang P. Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes. Diabetes Care. 2022 Feb 1;45(2):e32-e33. doi: 10.2337/dc21-1800.
Shao H, Kianmehr H, Guo J, Li P, Fonseca V, Shi L. Efficacy of iGlarLixi on 5-year risk of diabetes-related complications: A simulation study. J Diabetes Complications. 2022 Mar;36(3):108132. doi: 10.1016/j.jdiacomp.2022.108132.
Ahmed MM, Li P, Meece LE, Bian J, Shao H. A varied approach to left ventricular assist device follow-up improves cost-effectiveness. Curr Med Res Opin. 2021 Sep;37(9):1501-1505. doi: 10.1080/03007995.2021.1948395.
Li PP, Yan Y, Zhang HT, Cui SH, Wang CH, Wei W, Qian HG, Wang JC, Zhang Q. Biological activities of siRNA-loaded lanthanum phosphate nanoparticles on colorectal cancer. J Control Release. 2020 Dec 10;328:45-58. doi: 10.1016/j.jconrel.2020.08.027.
Li PP, Yan Y, Zhang HT, Wang R, Han HH, Wang JC. Treatment of cervical cancer by siRNA-loaded chitosan-coated calcium phosphate nanoparticles[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(8): 517-529.